Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers

Cancer Science

Volumn 98, Issue 3, 2007, Pages 299-307

  Yamanami, Hideaki ^a,b   Shiozaki, Kazuhiro ^a,c   Wada, Tadashi ^a   Yamaguchi, Kazunori ^a   Uemura, Takuji ^a   Kakugawa, Yoichiro ^b   Hujiya, Tsuneaki ^b   Miyagi, Taeko ^a,c  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Miyagi Cancer Center   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; GLYCOPROTEIN; ISOENZYME; LECTIN; MESSENGER RNA; PROTEIN NEU4; SIALIDASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL MOTILITY; CLINICAL ARTICLE; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; ENZYME ANALYSIS; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIN LAYER CHROMATOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; HCT116 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEURAMINIDASE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 33846675417     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00403.x     Document Type: Article

References (23)

1. Warren L, Buck CA, Tuszynski GP. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behaviour. Biochim Biophys Acta 1978; 516: 97-127.
2. Yogeeswaran G, Salk PL. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981; 212: 1514-16.
3. Fogel M, Altevogt P, Schirrmacher V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med. 1983; 157: 371-6.
4. Collard JG, Schijven JF, Bikker A, La Riviere G, Bolscher JG, Roos E. Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas. Cancer Res 1986; 46: 3521-7.
5. Dennis JW, LafartéS, Waghorne C, Breitman ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987; 236: 582-5.
6. Passaniti A, Hart GW. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures. J Biol Chem 1988; 263: 7591-603.
7. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: A minireview. Glycoconjugate J 2004; 20: 189-98.
8. Yamaguchi K, Hata K, Koseki K et.al. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 2005; 390: 85-93.
9. Monti E, Bassi MT, Bresciani R et al. Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family. Genomics 2004; 83: 445-53.
10. Seyrantepe V, Landry K, Trudel S, Hassan JA, Morales CR, Pshezhetsky AV. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. J Biol Chem 2004; 279: 37021-9.
11. Kato T, Wang Y, Yamaguchi K et al. Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells. Int J Cancer 2001; 92: 797-804.
12. Tokuyama S, Moriya S, Taniguchi S et al. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int J Cancer 1997; 73: 410-15.
13. Sawada M, Moriya S, Saito S et al. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer 2002; 97: 180-5.
14. Kakugawa Y, Wada T, Yamaguchi K et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA 2002; 99: 10718-23.
15. Ueno S, Saito S, Wada T et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 2006; 281: 7756-64.
16. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-9.
17. Miyagi T, Tsuiki S. Purification and characterization of cytosolic sialidase from rat liver. J Biol Chem 1985; 260: 6710-16.
18. Li K. Determination of sialic acids in human serum by reversed-phase liquid chromatography with fluorimatric detection. J Chromatogr 1992; 579: 209-13.
19. Kato K, Shiga K, Yamaguchi K et al. Plasma membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signaling. Biochem J 2006; 394: 647-56.
20. Holmstrom TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 1999; 19: 5991-6002.
21. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 2001; 276: 16484-90.
22. Hollingsworth MA, Swanson BJ. Mucins in cancer: Protection and control of the cell surface. Nature Rev Cancer 2004; 4: 45-60.
23. Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53- responsive gene transcription in the genetoxic stress response. Cancer Cell 2005; 7: 167-78.